Your Competitive Landscape Is Ready -

Time to Make Strategic Decisions

Strategic Insights & Competitive Intelligence

Competitor Monitoring Program & Ongoing CI Monitoring

Datum Pharma’s monitoring program collects data on critical aspects of competitors, such as clinical trials, pipeline updates, M&A activities, sales, and strategies.

Early Asset Evaluation for Decision Making

Early horizon scanning and market landscape assessments enable companies to make prudent decisions and avoid foreseeable clinical and commercial pitfalls.

These insights guide program progress, product line extensions, and partnering decisions, empowering early commercial teams and BD&L efforts.

Conference Planning and Reporting

Datum Pharma supports your conference activities with an Excel-based conference planner, pre-read reports, and post-conference reports with presentations that summarize the key findings and strategic takeaways from the events.

Market/Indication Landscape Assessments

Deep dive into global clinical trials to create actionable landscape reports, highlighting key assets (launched, approved, or in development) and estimated launch timelines.

Roadmap & Early Warning Monitoring

Understanding where competitors are heading is critical. Datum Pharma evaluates competitors’ R&D roadmaps to guide your own strategy.

Early Warning Monitoring identifies potential threats, leveraging an extensive network of experts and contacts to deliver timely insights.

Go-To-Market & Competitive Landscape Assessments

Datum Pharma provides a comprehensive view of competitors’ go-to-market strategies, including pricing, packaging, positioning, messaging, and differentiation.

Comprehensive view of specific diseases or markets, covering epidemiology, current treatments, pipeline drugs, competitors, helping you make informed strategic decisions.

It provides timely, actionable insights through customized executive summaries (monthly/quarterly) and rapid alerts with real-time news and key implications.

Competitor Pricing & Packaging Strategy

Are you priced higher or lower than your competitors? Datum Pharma’s multi-pronged research approach addresses information gaps and provides insights into pricing, discounting, bundling, and competitor packaging strategies to help you stay ahead of the competition

Real-Time Data & Pipeline Analysis

Access real-time data on product approvals, pending submissions, and launch timelines, enabling you to anticipate market shifts and make informed, strategic decisions.

Pipeline analysis provides in-depth tracking of emerging therapies and development progress.

Therapeutic Area Landscaping

Gain a competitive edge with in-depth therapeutic area landscaping, which uncovers key market trends and competitor strategies, helping you stay informed about opportunities and risks in new or existing therapeutic areas.

Track suppliers of finished formulations and APIs globally, including dossier statuses, licensing, market entry information, and detailed regulatory filings (e.g., DMFs, CEPs, WC) across multiple regions to stay informed about your supply chain and competitive position.

Datum Pharma’s patent landscape analysis helps you identify opportunities, mitigate risks, and optimize your market strategy by analyzing patent exclusivity periods, regulatory filings, and competitor IP strategies.

Company & Product Profiles

Unlock detailed company and product profiles, providing you with comprehensive data on market position, performance, and competitive landscape, empowering you to drive strategic growth.

Supplier & Manufacturers Tracking

Drug Patent Landscape Analysis

Market Positioning & Data-Driven Decision Making